SCHEMBL6158039

SCHEMBL6158039

Clc1ccc([N]Cc2ccc(-c3ccccc3)cc2)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.39
CCR2 P41597 2/20 0.39
AHR P35869 1/20 0.38
TAAR1 Q96RJ0 1/20 0.37
MAPK1 P28482 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
HTR3A P46098 1/20 0.37
HTR3D Q70Z44 1/20 0.37
HTR3C Q8WXA8 1/20 0.37
ESR2 Q92731 1/20 0.37
CSNK2A1 P68400 2/20 0.37
PTPN5 P54829 1/20 0.36
CYP1A2 P05177 1/20 0.36
IDO1 P14902 1/20 0.36
ADAMTS5 Q9UNA0 1/20 0.36
GRIN2B Q13224 1/20 0.36
S1PR1 P21453 1/20 0.35
S1PR5 Q9H228 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154495 0.79 CYP2A6 (0.42) SIGMAR1TAAR1MAPK1TDP1HTR3E
SCHEMBL6157029 0.78 TSHR (0.53) TSHR
SCHEMBL6155502 0.75 MEN1 (0.43) SIGMAR1CYP1A2GRIN2B
SCHEMBL29493845 0.71 AHR (0.74) AHRESR2CYP1A2IDO1TSHR
SCHEMBL1443418 0.71 AHR (0.74) AHRESR2CYP1A2IDO1TSHR
Water SCHEMBL11023201 0.69 AHR (0.70) AHRESR2CYP1A2IDO1TSHR
SCHEMBL6153827 0.68 TSHR (0.54) MAPK1TDP1CYP1A2TSHR
SCHEMBL6143031 0.68 TAAR1 (0.50) TAAR1CYP1A2IDO1GRIN2BTSHR
SCHEMBL6158041 0.67 FFAR1 (0.54) ADAMTS5S1PR1
SCHEMBL27817335 0.66 ALDH1A1 (0.55) MAPK1TDP1HTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP SIGMAR1 2793/4885CCR2 3196/4885AHR 2857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.